AOD-9604 5MG

AOD-9604 (Anti-Obesity Drug 9604) represents a refined advancement in metabolic research. Derived from a specific fragment of human growth hormone (HGH), this peptide was engineered to isolate HGH’s fat-mobilizing activity while avoiding its broader growth-related and hormonal effects. In essence, AOD-9604 captures the “lipolysis-specific signal” of HGH without engaging the full endocrine cascade.

This 16-amino-acid peptide has become a focal point in targeted fat metabolism research due to its ability to stimulate lipolysis without influencing growth pathways. By separating metabolic signaling from systemic hormonal activity, AOD-9604 provides researchers with a precise tool for studying adipose tissue regulation and energy balance.

AOD-9604’s scientific journey is particularly noteworthy. Originally investigated as a clinical candidate, it demonstrated a strong safety profile across multiple trials. While clinical outcomes varied, its exceptional tolerability and unique mechanism ultimately led to recognition as a GRAS (Generally Recognized As Safe) status nutraceutical ingredient, an uncommon distinction that continues to fuel interest in its research applications.

With a well-established safety record and a highly selective mode of action, AOD-9604 offers valuable insight into fat mobilization pathways without the confounding effects of full hormone exposure. Each vial contains high-purity, lyophilized peptide intended for reconstitution under laboratory conditions.